eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
5.52
-0.25 (-4.33%)
At close: Oct 5, 2026, 4:00 PM EDT
5.55
+0.03 (0.58%)
After-hours: Oct 5, 2026, 6:51 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $51.23 million as of October 5, 2026. Its market cap has decreased by -54.07% in one year.
Market Cap
51.23M
Enterprise Value
46.67M
1-Year Change
-54.07%
Ranking
Category
Stock Price
$5.52
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $51.23M, a decrease of -27.12%. That is a compound annual growth rate of -15.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 51.23M | -43.96% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 53.84M |
| ImageneBio | 53.35M |
| Apollomics | 52.84M |
| Edesa Biotech | 52.83M |
| LeonaBio | 52.57M |
| Serina Therapeutics | 51.82M |
| Dogwood Therapeutics | 51.67M |
| BioStem Technologies | 51.20M |